Grant Awarded for Manufacturing Biopharmeceuticals
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded Rensselaer a workforce development grant as part of a nearly $13 million round of recently announced funding, a value which includes cost sharing from participating organizations. The grant, in collaboration with Celegene and LumaCyte, LLC will, develop “characterization of cell therapy products by flow […]